Skip to content
Download PDF

Disorders of Ventilation

Chapter 307 | Part 7: Disorders of the Respiratory System · Part 7 – Respiratory Disorders · Chapter 307

Key Clinical Points

  1. Hypoventilation is defined as a PaCO2 ≥ 45 mmHg measured in arterial blood gas (ABG) analysis.
  2. A serum bicarbonate level < 27 mmol/L with normal renal function makes the diagnosis of hypoventilation very unlikely; values ≥ 27 mmol/L suggest hypercapnia and require ABG confirmation.
  3. Obesity Hypoventilation Syndrome (OHS) requires a BMI ≥ 30 kg/m² and chronic daytime alveolar hypoventilation (PaCO2 ≥ 45 mmHg at sea level).
  4. The pre-Bötzinger complex in the ventral respiratory column is essential for generating inspiratory activity; its lesion leads to complete cessation of breathing.
  5. Paradoxical breathing (abdomen moving inward during inspiration) indicates significant diaphragmatic weakness or paralysis.
  6. Chronic hypoventilation follows a progression: asymptomatic stage → nocturnal hypoventilation → decreased vital capacity/tidal volume → daytime hypercapnia.
  7. NIPPV for chronic hypercapnic COPD is indicated when PaCO2 > 52 mmHg and pH is normal, with the goal of reducing PaCO2 by 20% from baseline.
  8. Supplemental oxygen can worsen hypercapnia in patients with chronic hypercapnic COPD.
  9. Hamman's sign is a crunching or clicking noise synchronous with the heartbeat, best heard on the anterior chest wall in the left lateral decubitus position.
  10. Congenital central hypoventilation syndrome (CCHS), also known as Ondine's curse, is characterized by an absent respiratory response to hypoxia or hypercapnia.

1. DEFINITION & OVERVIEW

• Definition: In health, arterial carbon dioxide (PaCO2) is maintained between 37 and 43 mmHg at sea level. • Alveolar Hypoventilation: Insufficient alveolar ventilation to maintain PaCO2 in the normal physiologic range. This can occur due to inappropriate levels of minute ventilation or an increased dead space fraction (VD/VT). • Hyperventilation: Ventilation in excess of metabolic requirements (CO2 production) leading to a reduction in PaCO2.

1.1 Alveolar Ventilation Physiology

• Relationship Equation: PaCO2 = (k) (VCO2)/VA ◦ VCO2: Carbon dioxide production. ◦ VA: Fresh gas alveolar ventilation. • Minute vs. Alveolar Ventilation: ◦ Not equivalent due to dead space. ◦ VA = minute ventilation imes (1 - VD/VT). • Clinical Significance: All disturbances of PaCO2 must reflect altered VCO2, minute ventilation, or dead space fraction.

1.2 Respiratory Cycle Control

• Medullary Centers: ◦ Dorsal respiratory group (DRG): Initial integration site for afferent nerves (PaO2, PaCO2, pH, blood pressure). ◦ Ventral respiratory column (VRC): Generates respiratory rhythm. • Pre-Bötzinger Complex: Located within the VRC; responsible for generating various forms of inspiratory activity. → Lesioning leads to complete cessation of breathing. • Parafacial Respiratory Group (pFRG): Important for the generation of active expiration.

1.3 Respiratory Pump Mechanics

• Balance Concept: Normal gas exchange requires respiratory muscle strength to overcome elastic and resistive loads (Figure 307-1). • Hypoventilation Scenario: Reduced drive or neuromuscular competence OR increased respiratory load → diminished minute ventilation → hypercapnia. • Hyperventilation Scenario: Normal muscle strength coupled with excessive respiratory drive → alveolar hyperventilation → hypocapnia.

2. EPIDEMIOLOGY

• Obesity Hypoventilation Syndrome (OHS): ◦ Estimated prevalence: up to 0.4% of the U.S. adult population. ◦ Risk factors: Severe obesity (BMI > 40 kg/m²) and severe OSA (AHI > 30 events per h).

3. ETIOLOGY & PATHOPHYSIOLOGY

• Pathophysiology of Hypoventilation: → Increase in alveolar PCO2 (PAco2) → increase in PaCO2. → Resulting chronic respiratory acidosis → compensatory increase in plasma bicarbonate. → Increased PaCO2 displaces oxygen in the alveolus → decreased PAO2 → hypoxemia. → Chronic hypoxemia → stimulated erythropoiesis → secondary erythrocytosis. → Combination of hypoxemia and hypercapnia → pulmonary vasoconstriction → pulmonary hypertension, RVH, and right heart failure. • Categories of Hypoventilation: 1. Parenchymal lung and chest wall disease 2. Obesity 3. Neuromuscular disease 4. Respiratory drive disorders

3.2 Hyperventilation Etiologies

• Clinical Presentation: Symptoms include dyspnea, paresthesias, tetany, headache, dizziness, visual disturbances, and atypical chest pain. → Often misattributed to cardiopulmonary disorders due to the alarming nature of symptoms. → Anxiety/panic are not synonymous with hyperventilation but can be initiating or sustaining factors.

4. CLINICAL FEATURES

• General Symptoms: Varies by severity, rate of hypercapnia development, and degree of compensation. • Lung/Chest Wall Disease: Shortness of breath, diminished exercise tolerance, sputum production (obstructive), or progressive dyspnea/cough (interstitial). • Sleep-Disordered Breathing/OHS: Excessive daytime somnolence, poor-quality sleep, snoring. • Neuromuscular Disorders: → Early sign: New-onset orthopnea (heralds reduced respiratory muscle force). → Progression: Extremity weakness or bulbar symptoms before respiratory involvement. → Physical Exam: Paradoxical breathing (abdomen moving inward during inspiration) → indicates diaphragmatic weakness/paralysis. • Respiratory Drive Disorders: Symptoms are usually indistinguishable from other causes; diagnosis is by exclusion. • Hamman's Sign: Crunching or clicking noise synchronous with the heartbeat, heard on the anterior chest wall in the left lateral decubitus position.

4.1 Signs and Symptoms of Hypoventilation (Table 307-1)

• Chest wall loads: Orthopnea, Poor-quality sleep, Daytime hypersomnolence, Early morning headaches, Anxiety, Impaired cough. → Associated with: Lung resistive/elastic loads, Kyphoscoliosis, Myasthenia gravis, Phrenic nerve injury, Spinal cord lesion.

5. DIFFERENTIAL DIAGNOSIS

• Initial Focus: Determine if lung disease or chest wall abnormalities are present (via physical exam, CXR, CT, and PFTs). • Secondary Focus: If lung/chest wall are normal → evaluate respiratory pump (drive and neuromuscular disorders). → Rule out secondary causes: Sedating medications, chronic narcotic use, or metabolic derangements (e.g., hypothyroidism). • Primary Respiratory Drive Disorders: Suspected when patient has hypercapnia but shows normal muscle strength, normal pulmonary function, and normal A-a PO2 gradient.

6. INVESTIGATIONS & DIAGNOSIS

• Obesity Hypoventilation Syndrome (OHS) Criteria: → Requirement: BMI ≥ 30 kg/m² and chronic daytime alveolar hypoventilation (PaCO2 ≥ 45 mmHg). → Risk factors: Severe obesity (BMI > 40), severe OSA (AHI > 30). • Neuromuscular Disease Criteria: → NIPPV Initiation (ALS Guidelines): If symptoms exist AND one of the following is met: 1. PaCO2 ≥ 45 mmHg. 2. Nocturnal oximetry: Oxygen saturation ≤ 88% for 5 consecutive min. 3. Maximal inspiratory pressure (MIP) < 60 cmH2O. 4. Sniff nasal pressure < 40 cmH2O AND FVC < 50% predicted. • Screening Tools: → Epworth Sleepiness Scale (ESS): Measures daytime sleepiness. → Berlin Questionnaire: Validated in primary care to identify likely OSA. → STOP-Bang survey: Used in preoperative clinics to identify risk of OSA. → Polysomnography (PSG): Required for definitive diagnosis of OSA and screening for nocturnal hypoventilation.

7. MANAGEMENT & TREATMENT

  1. NIPPV Initiation: → For chronic hypercapnic COPD: Indicated if PaCO2 > 52 mmHg and normal pH. → Goal: Reduce PaCO2 by 20% from baseline.
  2. Oxygen Therapy: → Used for hypoxemia, polycythemia, and pulmonary hypertension. → Caution: May worsen hypercapnia in some patients with chronic hypercapnic COPD.
  3. Obesity Hypoventilation Syndrome Treatment: → Weight reduction (20-25% of body weight) can normalize PaCO2. → CPAP for those with concurrent severe OSA. → BiPAP (spontaneous mode) if CPAP not tolerated or high pressure needed. → BiPAP ST or volume-assured pressure support if hypercapnia persists after several weeks of CPAP.
  4. Neuromuscular/Chest Wall Treatment: → Phrenic nerve or diaphragm pacing for high cervical spinal cord lesions or respiratory drive disorders. → Requirement: Pre-surgical nerve conduction studies to ensure bilateral phrenic function. → Cough Assist Devices: Used for patients with ineffective cough to reduce risk of pneumonia. → Pharmacology: Medroxyprogesterone and acetazolamide are poorly studied; should not replace primary treatment.

8. PROGNOSIS & COMPLICATIONS

• Clinical Course of Hypoventilation: 1. Asymptomatic stage (Daytime PaO2/PaCO2 normal). 2. Nocturnal hypoventilation (initially REM, then non-REM). 3. Decreased vital capacity and tidal volume. 4. Daytime hypercapnia. • Complications of Chronic Hypoventilation: → Respiratory acidosis → increased bicarbonate. → Pulmonary vasoconstriction → pulmonary hypertension → right ventricular hypertrophy → right heart failure.

9. SPECIAL CONSIDERATIONS

• Respiratory Drive Disorders: Often secondary in nature; a cause can usually be identified with a detailed medical history, including medications or illicit drug use.

10. KEY PEARLS & CLINICAL TRAPS

• Bicarbonate Rule: Serum bicarbonate < 27 mmol/L with normal renal function makes hypoventilation unlikely. → If ≥ 27 mmol/L, order ABG to confirm hypercapnia. • Paradoxical Breathing: A hallmark of diaphragmatic failure; abdomen moves inward during inspiration. • Oxygen Risk: In chronic hypercapnic COPD, supplemental oxygen can worsen hypercapnia. • OHS Diagnosis: Requires both BMI ≥ 30 kg/m² and PaCO2 ≥ 45 mmHg.

11. WHAT TO LOOK FOR — DIAGNOSTIC CLUES

• Pneumomediastinum: (Not specified in source text; check for clinical context). • Neuromuscular Weakness: → Look for: Paradoxical breathing, reduced respiratory muscle force, and impaired cough.

12. WHAT EXCLUDES THE DIAGNOSIS

• Serum Bicarbonate Threshold: → Serum bicarbonate < 27 mmol/L with normal renal function makes the diagnosis of hypoventilation very unlikely.

Flowcharts & Algorithms

Diagnostic Algorithm for Hypoventilation Etiology (Figure 307-2): 1. Initial Assessment: Evaluate chest wall and pulmonary imaging. 2. PFTs & Imaging Results: Determine if findings suggest lung disease, chest wall abnormality, or other issues. 3. Muscle Strength Testing: Measure MIP and MEP in seated/supine positions. → If abnormal: Differentiate between Lung disease (Obstructive/Restrictive) and Neuromuscular disease (Systemic/Local). 4. BMI Assessment: If BMI ≥ 30 kg/m² and other causes are ruled out → Obesity hypoventilation syndrome. → Step: Perform PSG to rule out OSA. 5. CNS Evaluation: Perform imaging (CT/MRI) to identify CNS lesions (Stroke, Tumor).